Category icon
The Science of Ultrasound Renal Denervation

Philipp Lurz, Michael Joner, Felix Mahfoud et al

Category icon
Hypertension and Frailty Syndrome in Old Age: Current Perspectives

Izabella Uchmanowicz, Anna Chudiak, Beata Jankowska-Polańska, et al

Category icon
Practical Applications for Single Pill Combinations in the Cardiovascular…

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz, et al

Category icon
Treating Acute Heart Failure with Chronic Obstructive Pulmonary Disease

Jelena Celutkiene, Mindaugas Balčiūnas, Denis Kablučko, et al

Category icon
Corrigendum to: Pulmonary Hypertension in Heart Failure Patients

Sriram D Rao, Srinath Adusumalli, Jeremy A Mazurek,

Category icon
Pulmonary Hypertension in Heart Failure Patients

Sriram D Rao, Srinath Adusumalli, Jeremy A Mazurek,

Category icon
PVI Versus Amiodarone in AF and CHF

Michela Faggioni, Domenico G Della Rocca, Sanghamitra Mohanty, et al

Category icon
Treating Acute Heart Failure with Chronic Obstructive Pulmonary Disease

Jelena Celutkiene, Mindaugas Balčiūnas, Denis Kablučko, et al

Category icon
Practical Applications for Single Pill Combinations in the Cardiovascular…

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz, et al

Category icon
The Science of Ultrasound Renal Denervation

Philipp Lurz, Michael Joner, Felix Mahfoud et al

Category icon
Hypertension and Frailty Syndrome in Old Age: Current Perspectives

Izabella Uchmanowicz, Anna Chudiak, Beata Jankowska-Polańska, et al

Category icon
Pulmonary Hypertension in Heart Failure Patients

Sriram D Rao, Srinath Adusumalli, Jeremy A Mazurek,

Category icon
PVI Versus Amiodarone in AF and CHF

Michela Faggioni, Domenico G Della Rocca, Sanghamitra Mohanty, et al

Category icon
Corrigendum to: Pulmonary Hypertension in Heart Failure Patients

Sriram D Rao, Srinath Adusumalli, Jeremy A Mazurek,

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles

Articles

Article icon
Hypertension and Frailty Syndrome in Old Age: Current Perspectives

Izabella Uchmanowicz, Anna Chudiak, Beata Jankowska-Polańska,

Citation: Cardiac Failure Review 2017;3(2):102–7.

Practical Applications for Single Pill Combinations in the Cardiovascular…

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz,

Citation: Cardiac Failure Review 2017;3(1):40–5.

Treating Acute Heart Failure with Chronic Obstructive Pulmonary Disease

Jelena Celutkiene, Mindaugas Balčiūnas, Denis Kablučko,

Citation: Cardiac Failure Review 3(1):56–61.

Corrigendum to: Pulmonary Hypertension in Heart Failure Patients

Sriram D Rao, Srinath Adusumalli, Jeremy A Mazurek,

Published:

Citation: Cardiac Failure Review 2020;6:e30.